Company intelligence / Profile preview

Xigo Health

Ownership: Private
Development stage: Other

Overview

Xigo Health developed a patent-pending chewable immunity supplement combining beta-glucans, L-glutamine, and lactoferrin. A clinical trial was underway in 2010 to assess efficacy against common cold symptoms; no published results are available. The company focused on supporting family health through natural supplements and education but is now inactive.

Therapeutic areas: ImmunologyInfectious Diseases
Modalities: ProteinAmino acidPolysaccharide
Industry: Food & Nutrition

Beyond the preview

Go deeper on Xigo Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xigo Health.

Explore the full profile